Related Experiment Video
Updated: Jul 9, 2025
10:02
Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells
Published on: June 10, 2022
2.2K
Considerations on the Design of Lipid-based mRNA Vaccines Against Cancer
Sofie Meulewaeter1, Yao Zhang2, Abishek Wadhwa3
1Laboratory of General Biochemistry and Physical Pharmacy, Faculty of Pharmaceutical Sciences, Ghent University, Ghent 9000, Belgium; Cancer Research Institute Ghent (CRIG), Ghent University Hospital, Ghent University, Ghent 9000, Belgium.
Journal of Molecular Biology
|December 8, 2023
Summary
Messenger RNA (mRNA) vaccines show promise for cancer immunotherapy, with ongoing research into modifications, lipid carriers, and delivery methods to enhance potency and efficacy in cancer treatment.
Area of Science:
- Oncology
- Immunology
- Biotechnology
Background:
- Messenger RNA (mRNA) vaccine technology, spurred by COVID-19, is increasingly explored for cancer immunotherapy.
- Lipid-based mRNA vaccines have demonstrated promising clinical trial results for cancer therapy.
- Significant variations exist in mRNA modifications, lipid carriers, and administration routes for cancer mRNA vaccines compared to those for infectious diseases.
Purpose of the Study:
- To review how mRNA modification, lipid carriers, and administration routes influence the potency of mRNA cancer vaccines.
- To explore the interplay between these factors in enhancing cancer vaccine efficacy and safety.
- To summarize current and emerging strategies for improving mRNA cancer vaccine performance.
Main Methods:
- Literature review of recent clinical trials and research on mRNA cancer vaccines.
- Analysis of factors affecting mRNA vaccine potency, including lipid carrier composition and targeting.
- Synthesis of data on strategies to optimize mRNA cancer vaccine efficacy.
Main Results:
- Lipid carrier composition can be optimized for passive targeting to immune cells, potentially improving mRNA vaccine efficacy and safety.
- Differences in mRNA modification, lipid carriers, and administration routes significantly impact the potency of cancer vaccines.
- Various strategies are being developed to enhance the effectiveness of mRNA cancer vaccines.
Conclusions:
- Optimizing mRNA vaccine components and delivery is crucial for advancing cancer immunotherapy.
- Further research into lipid carrier design and targeting strategies can improve mRNA cancer vaccine outcomes.
- Next-generation mRNA cancer vaccines are on the horizon, offering new therapeutic possibilities.
More Related Videos
Related Concept Videos
01:30Cancer Vaccines
376
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
376
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
02:28Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K